Edinburgh Research Explorer

Anticancer drug-induced BH3-only protein.Bak interactions

Project: Research

StatusFinished
Effective start/end date16/04/1231/03/17
Total award£47,607.00
Funding organisationNon-EU-based charities
Funder project reference1r012ca166741-01
Period16/04/1231/03/17